Skip to main content
. Author manuscript; available in PMC: 2016 Feb 2.
Published in final edited form as: Drug Metab Rev. 2015 Feb 2;47(1):21–28. doi: 10.3109/03602532.2014.1003648

Table 1.

Summary of mechanistic studies performed with recombinant CYP3A4 and CYP3A5 (Takakusa et al., Barbara et al., Chan et al.)

Mechanistic studies CYP3A4 CYP3A5 Interpretation
GSH trapping Yes Yes Indicates formation of electrophilic metabolite capable of covalent binding
GSH protection from inactivation Data not available Yes Indicates electrophilic metabolite release from active site
Reversal of inactivation via dialysis Data not available No Indicates non-covalent inactivation, likely via MI complex of the heme iron
Formation of Soret peak Yes No Indicates coordination of heme iron through a metabolite-intermediate complex
Reduced CO difference spectroscopy Yes Yes Decrease in absorbance at 450 nm indicates alkylation of heme or adduction of the apoprotein vicinal to the heme
Reversal of inactivation by ferricyanide Yes No Reversal indicates a non-covalent inactivation; Absence of reversal indicates covalent adduction
Mass shift of intact protein by mass spectrometry No Data not available Indicates covalent binding to apoprotein or heme